Research Presentation Sessions: Oncologic Imaging

RPS 716 - Advanced imaging in lung oncology

Lectures

1
Introduction by the moderator

Introduction by the moderator

04:00Martine Rémy-Jardin, Lille / FR

2
Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients

Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients

08:00Gianluca Milanese, Parma / IT

3
Evaluation of differential response in patients with metastatic lung cancer treated with immune checkpoint inhibitors: a pilot study

Evaluation of differential response in patients with metastatic lung cancer treated with immune checkpoint inhibitors: a pilot study

08:00Andreu Antolín Redondo, Barcelona / ES

4
Comparison of performance by whole-body MRI, PET/MRI and PET/CT and conventional staging methods for TNM and VALSG staging of small cell carcinoma patients

Comparison of performance by whole-body MRI, PET/MRI and PET/CT and conventional staging methods for TNM and VALSG staging of small cell carcinoma patients

08:00Yoshiharu Ohno, Toyoake / JP

5
To differentiate pulmonary sclerosing pneumocytoma from atypical lung cancer based-on contrast-enhanced CT: a radiomic analysis

To differentiate pulmonary sclerosing pneumocytoma from atypical lung cancer based-on contrast-enhanced CT: a radiomic analysis

08:00Lei Wang, Nanchang / CN

6
Differentiation of benign lung nodules and lung metastases: a radiomics approach in a large cancer patient cohort

Differentiation of benign lung nodules and lung metastases: a radiomics approach in a large cancer patient cohort

08:00Simon Lennartz, Köln / DE